An expert discusses strategies for monitoring response to treatment, including observation, Epstein-Barr virus (EBV) titers, ...

The vaccine “induced” a persistent two- to four-fold increase in serum neutralising antibody titers through week 4 from baseline, with titers continuing to rise between week 2 and 4.